• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Torasemide-induced IgA vasculitis in a patient with heart failure.

作者信息

Yu Lin-Yu, Liu Liang-Yu, Tan Deng-Hang, Tian Hai-Fen, Zheng Ping

机构信息

Department of Pharmacy, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.

Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.

出版信息

J Geriatr Cardiol. 2023 Jul 28;20(7):548-550. doi: 10.26599/1671-5411.2023.07.004.

DOI:10.26599/1671-5411.2023.07.004
PMID:37576483
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10412542/
Abstract
摘要

相似文献

1
Torasemide-induced IgA vasculitis in a patient with heart failure.托拉塞米诱发心力衰竭患者发生IgA血管炎。
J Geriatr Cardiol. 2023 Jul 28;20(7):548-550. doi: 10.26599/1671-5411.2023.07.004.
2
Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.托拉塞米致嗜酸性肉芽肿伴多血管炎血管性紫癜。
Acta Dermatovenerol Croat. 2022 Sep;30(2):116-118.
3
Pharmacokinetics and pharmacodynamics of torasemide in congestive heart failure.托拉塞米在充血性心力衰竭中的药代动力学和药效学
Cardiology. 1994;84 Suppl 2:108-14. doi: 10.1159/000176463.
4
The impact of torasemide on haemodynamic and neurohormonal stress, and cardiac remodelling in heart failure - TORNADO: a study protocol for a randomized controlled trial.托拉塞米对心力衰竭患者血流动力学、神经激素应激及心脏重塑的影响——TORNADO：一项随机对照试验的研究方案
Trials. 2017 Jan 23;18(1):36. doi: 10.1186/s13063-016-1760-z.
5
TORAFIC study protocol: torasemide prolonged release versus furosemide in patients with chronic heart failure.托拉非克研究方案：慢性心力衰竭患者中托拉塞米缓释剂与呋塞米的对比研究
Expert Rev Cardiovasc Ther. 2009 Aug;7(8):897-904. doi: 10.1586/erc.09.74.
6
Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.托拉塞米和呋塞米在欧洲心脏病学会心力衰竭注册中心心力衰竭患者中的长期结局比较分析。
Cardiovasc Drugs Ther. 2019 Feb;33(1):77-86. doi: 10.1007/s10557-018-6843-5.
7
Torasemide: a pharmacoeconomic review of its use in chronic heart failure.托拉塞米：对其用于慢性心力衰竭的药物经济学综述
Pharmacoeconomics. 2001;19(6):679-703. doi: 10.2165/00019053-200119060-00006.
8
Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.托拉塞米与呋塞米治疗心力衰竭的疗效比较：一项随机对照试验的系统评价和荟萃分析。
J Eval Clin Pract. 2020 Jun;26(3):842-851. doi: 10.1111/jep.13261. Epub 2019 Aug 21.
9
Torasemide reduces dilated cardiomyopathy, complication of arrhythmia, and progression to heart failure.托拉塞米可减轻扩张型心肌病、心律失常并发症以及向心力衰竭的进展。
Genet Mol Res. 2014 Sep 5;13(3):7262-74. doi: 10.4238/2014.September.5.11.
10
Randomized, open-label, blinded-endpoint, crossover, single-dose study to compare the pharmacodynamics of torasemide-PR 10 mg, torasemide-IR 10 mg, and furosemide-IR 40 mg, in patients with chronic heart failure.一项随机、开放标签、盲终点、交叉、单剂量研究，旨在比较托拉塞米-PR 10毫克、托拉塞米-IR 10毫克和呋塞米-IR 40毫克在慢性心力衰竭患者中的药效学。
Drug Des Devel Ther. 2015 Aug 5;9:4291-302. doi: 10.2147/DDDT.S86300. eCollection 2015.

本文引用的文献

1
The coexistence of IgA vasculitis and tuberculosis: a case-based review.IgA血管炎与结核病的共存：基于病例的综述
Rheumatol Int. 2021 Sep;41(9):1683-1689. doi: 10.1007/s00296-021-04922-3. Epub 2021 Jun 16.
2
Heart failure in the elderly.老年人心力衰竭
J Geriatr Cardiol. 2021 Mar 28;18(3):219-232. doi: 10.11909/j.issn.1671-5411.2021.03.009.
3
Drug-induced IgA vasculitis in children and adults: Revisiting drug causality using a dual pharmacovigilance-based approach.药物诱导的儿童和成人 IgA 血管炎：应用双重基于药物警戒的方法重新评估药物因果关系。
Autoimmun Rev. 2021 Jan;20(1):102707. doi: 10.1016/j.autrev.2020.102707. Epub 2020 Nov 14.
4
Rifampin Induced Thrombotic Thrombocytopenic Purpura.利福平诱发的血栓性血小板减少性紫癜
Indian J Hematol Blood Transfus. 2020 Jul;36(3):575-577. doi: 10.1007/s12288-019-01249-9. Epub 2020 Jan 10.
5
Diuretic Therapy for Patients With Heart Failure: JACC State-of-the-Art Review.心力衰竭患者的利尿剂治疗：JACC 最新综述。
J Am Coll Cardiol. 2020 Mar 17;75(10):1178-1195. doi: 10.1016/j.jacc.2019.12.059.
6
Torasemide versus furosemide in treatment of heart failure: A systematic review and meta-analysis of randomized controlled trials.托拉塞米与呋塞米治疗心力衰竭的疗效比较：一项随机对照试验的系统评价和荟萃分析。
J Eval Clin Pract. 2020 Jun;26(3):842-851. doi: 10.1111/jep.13261. Epub 2019 Aug 21.
7
Comparative Analysis of Long-Term Outcomes of Torasemide and Furosemide in Heart Failure Patients in Heart Failure Registries of the European Society of Cardiology.托拉塞米和呋塞米在欧洲心脏病学会心力衰竭注册中心心力衰竭患者中的长期结局比较分析。
Cardiovasc Drugs Ther. 2019 Feb;33(1):77-86. doi: 10.1007/s10557-018-6843-5.
8
Cutaneous leukocytoclastic vasculitis associated with anti-tuberculosis drugs.与抗结核药物相关的皮肤白细胞破碎性血管炎。
Pediatr Int. 2015;57(1):155-7. doi: 10.1111/ped.12403.
9
IgA vasculitis (Henoch-Shönlein purpura) in adults: Diagnostic and therapeutic aspects.成人 IgA 血管炎（过敏性紫癜）：诊断与治疗方面。
Autoimmun Rev. 2015 Jul;14(7):579-85. doi: 10.1016/j.autrev.2015.02.003. Epub 2015 Feb 14.
10
Isoniazid Induced Cutaneous Leukocytoclastic Vasculitis in Extra Pulmonary Tuberculosis (Pott's Spine): A Case Report.异烟肼诱发肺外结核（波特氏脊柱炎）患者的皮肤白细胞破碎性血管炎：一例报告
J Clin Diagn Res. 2014 Aug;8(8):MD03-5. doi: 10.7860/JCDR/2014/9000.4688. Epub 2014 Aug 20.